Imexpharm Balance Sheet

Financials in millions VND. Fiscal year is January - December.

Millions VND. Fiscal year is Jan - Dec.

Fiscal Year	TTM	FY 2025	FY 2024	FY 2023	FY 2022	FY 2021
Period Ending	Mar '26 Mar 31, 2026	Dec '25 Dec 31, 2025	Jan '25 Jan 1, 2025	Jan '24 Jan 1, 2024	Dec '22 Dec 31, 2022	Dec '21 Dec 31, 2021
Cash & Equivalents	75,791	189,193	161,983	106,201	178,845	271,273
Short-Term Investments	386,016	212,102	142,000	93,000	211,300	111,300
Trading Asset Securities	-	-	-	-	-	1,153
Cash & Short-Term Investments	461,807	401,296	303,983	199,201	390,145	383,726
Cash Growth	1.42%	32.01%	52.60%	-48.94%	1.67%	157.75%
Accounts Receivable	386,522	323,278	334,746	254,058	228,770	241,946
Other Receivables	8,864	4,036	4,030	4,066	-1,000	11,995
Receivables	395,386	327,314	338,776	258,124	227,770	255,941
Inventory	639,116	677,715	705,082	699,446	435,841	492,075
Prepaid Expenses	-	21,304	15,564	6,539	1,601	3,155
Other Current Assets	45,083	79,783	46,139	43,825	48,195	41,443
Total Current Assets	1,541,392	1,507,411	1,409,544	1,207,135	1,103,553	1,176,340
Property, Plant & Equipment	728,312	745,246	828,489	908,754	996,450	955,680
Long-Term Investments	97,088	66,959	66,959	71,284	71,290	50,962
Other Intangible Assets	72,546	73,215	74,219	74,150	72,978	73,581
Other Long-Term Assets	964.27	389,804	125,566	131,293	32,672	38,136
Total Assets	2,820,855	2,782,634	2,504,777	2,392,615	2,276,944	2,294,700
Accounts Payable	89,665	80,783	77,044	70,505	87,542	92,713
Accrued Expenses	76,293	102,784	89,231	144,776	139,803	100,346
Short-Term Debt	99,958	112,779	86,122	49,422	-	80,491
Current Portion of Long-Term Debt	-	-	-	-	94,980	91,652
Current Income Taxes Payable	20,796	27,727	31,631	19,107	25,382	17,141
Current Unearned Revenue	28,189	-	-	-	-	-
Other Current Liabilities	23,734	48,360	37,630	24,227	34,789	26,295
Total Current Liabilities	338,635	372,432	321,657	308,036	382,497	408,638
Long-Term Debt	100,000	100,000	-	-	-	91,652
Other Long-Term Liabilities	3,680	3,680	-	-	-	-
Total Liabilities	442,315	476,112	321,657	308,036	382,497	500,290
Common Stock	1,540,428	1,540,428	1,540,428	700,384	667,054	667,054
Additional Paid-In Capital	187,323	187,323	187,323	507,368	507,368	507,368
Retained Earnings	648,728	576,709	453,306	874,764	717,963	617,926
Treasury Stock	-358.6	-358.6	-358.6	-358.6	-358.6	-358.6
Comprehensive Income & Other	2,421	2,421	2,421	2,421	2,421	2,421
Shareholders' Equity	2,378,541	2,306,522	2,183,119	2,084,579	1,894,447	1,794,410
Total Liabilities & Equity	2,820,855	2,782,634	2,504,777	2,392,615	2,276,944	2,294,700
Total Debt	199,958	212,779	86,122	49,422	94,980	263,795
Net Cash (Debt)	261,849	188,516	217,862	149,779	295,165	119,931
Net Cash Growth	294.50%	-13.47%	45.46%	-49.26%	146.11%	568.18%
Net Cash Per Share	1700.22	1224.06	1414.60	972.53	1916.53	778.71
Filing Date Shares Outstanding	154.01	154.01	154.01	154.01	154.01	154.01
Total Common Shares Outstanding	154.01	154.01	154.01	154.01	154.01	154.01
Working Capital	1,202,758	1,134,979	1,087,886	899,099	721,056	767,702
Book Value Per Share	15444.17	14976.55	14175.27	13535.33	12300.70	11651.16
Tangible Book Value	2,305,995	2,233,308	2,108,900	2,010,429	1,821,469	1,720,829
Tangible Book Value Per Share	14973.12	14501.15	13693.36	13053.86	11826.85	11173.39
Buildings	385,312	385,312	384,650	384,597	299,061	298,602
Machinery	1,107,138	1,101,466	1,088,549	1,066,310	638,041	601,972
Construction In Progress	39,881	37,418	43,897	47,351	580,743	519,463

Source: S&P Global Market Intelligence. Standard template. Financial Sources.